Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000211541 | SCV000268434 | uncertain significance | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2015-02-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000498567 | SCV000590781 | uncertain significance | not provided | 2017-06-29 | criteria provided, single submitter | clinical testing | The c.-17 C>G variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.-17 C>G variant is observed in 5/10186 (0.05%) alleles from individuals of African background in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This nucleotide substitution occurs at a position that is not conserved. Several in-silico splice prediction models predict that c.-17 C>G does not affect normal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. In summary, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Counsyl | RCV000211541 | SCV000793503 | uncertain significance | Medium-chain acyl-coenzyme A dehydrogenase deficiency | 2017-08-17 | criteria provided, single submitter | clinical testing |